RFS
TEVA icon

Rockefeller Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History

Rockefeller Financial Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$27K Hold
1,422
– – ﹤0.01% 454
2017
Q3 		$25K Hold
1,422
– – ﹤0.01% 462
2017
Q2 		$47K Hold
1,422
– – ﹤0.01% 384
2017
Q1 		$46K Hold
1,422
– – ﹤0.01% 404
2016
Q4 		$52K Buy
1,422
+72
+5% +$2.88K ﹤0.01% 418
2016
Q3 		$62K Hold
1,350
– – ﹤0.01% 383
2016
Q2 		$68K Sell
1,350
-1,560
-54% -$83K ﹤0.01% 382
2016
Q1 		$156K Buy
2,910
+1,063
+58% +$62.4K ﹤0.01% 338
2015
Q4 		$121K Hold
1,847
– – ﹤0.01% 377
2015
Q3 		$104K Buy
1,847
+497
+37% +$32.2K ﹤0.01% 377
2015
Q2 		$80K Sell
1,350
-3,500
-72% -$216K ﹤0.01% 379
2015
Q1 		$302K Buy
4,850
+2,710
+127% +$158K 0.01% 285
2014
Q4 		$123K Buy
2,140
+790
+59% +$44K ﹤0.01% 332
2014
Q3 		$73K Sell
1,350
-470
-26% -$24.9K ﹤0.01% 389
2014
Q2 		$95K Buy
1,820
+470
+35% +$24K ﹤0.01% 383
2014
Q1 		$71K Hold
1,350
– – ﹤0.01% 413
2013
Q4 		$54K Hold
1,350
– – ﹤0.01% 415
2013
Q3 		$51K Hold
1,350
– – ﹤0.01% 416
2013
Q2 		$53K Buy
+1,350
New +$52.6K ﹤0.01% 414

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Rockefeller Financial Services's TEVA Position: Q4 2017 in Review

Rockefeller Financial Services held its Teva Pharmaceuticals (TEVA) position steady in Q4 2017 at 1,422 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #454.

Rockefeller Financial Services first reported a position in TEVA in Q2 2013 and has held it in 19 quarters since. The position peaked at $302K in Q1 2015. 507 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • Rockefeller Financial Services held 1,422 shares of Teva Pharmaceuticals worth $27K as of Q4 2017.
  • Rockefeller Financial Services left its Teva Pharmaceuticals share count unchanged in Q4 2017.
  • Teva Pharmaceuticals made up ﹤0.01% of Rockefeller Financial Services's portfolio in Q4 2017, its #454 holding.
  • Rockefeller Financial Services first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 19 quarters since.
  • Rockefeller Financial Services's Teva Pharmaceuticals position peaked at $302K in Q1 2015.
  • 507 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.